These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37149156)

  • 21. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
    Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
    Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic external evaluation of reported population pharmacokinetic models of vancomycin in Chinese children and adolescents.
    Lv C; Lu J; Jing L; Liu TT; Chen M; Zhang R; Li C; Zhou S; Wei Y; Chen Y
    J Clin Pharm Ther; 2021 Jun; 46(3):820-831. PubMed ID: 33751618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Mogle BT; Steele JM; Seabury RW; Dang UJ; Kufel WD
    Int J Antimicrob Agents; 2018 Dec; 52(6):805-810. PubMed ID: 30176357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using Electronic Health Records for Personalized Dosing of Intravenous Vancomycin in Critically Ill Neonates: Model and Web-Based Interface Development Study.
    Hui KHM; Lam HS; Chow CHT; Li YSJ; Leung PHT; Chan LYB; Lee CP; Ewig CLY; Cheung YT; Lam TNT
    JMIR Med Inform; 2022 Jan; 10(1):e29458. PubMed ID: 35099393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin therapeutics and monitoring: a contemporary approach.
    Avent ML; Vaska VL; Rogers BA; Cheng AC; van Hal SJ; Holmes NE; Howden BP; Paterson DL
    Intern Med J; 2013 Feb; 43(2):110-9. PubMed ID: 23185970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients.
    Mena M; Garcia JC; Bustos RH
    Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-center prospective population pharmacokinetic study and the performance of web-based individual dose optimization application of intravenous vancomycin for adults in Hong Kong: A study protocol.
    Hui KHM; Lui CYG; Wu KLA; Chen J; Cheung YT; Lam TNT
    PLoS One; 2022; 17(5):e0267894. PubMed ID: 35511796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic drug monitoring of imatinib: Bayesian and alternative methods to predict trough levels.
    Gotta V; Widmer N; Montemurro M; Leyvraz S; Haouala A; Decosterd LA; Csajka C; Buclin T
    Clin Pharmacokinet; 2012 Mar; 51(3):187-201. PubMed ID: 22339450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosing vancomycin in the super obese: less is more.
    Crass RL; Dunn R; Hong J; Krop LC; Pai MP
    J Antimicrob Chemother; 2018 Nov; 73(11):3081-3086. PubMed ID: 30203073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hospital Pharmacometrics for Optimal Individual Administration of Antimicrobial Agents for Anti-methicillin-resistant Staphylococcus aureus Infected Patients.
    Tsuji Y
    Biol Pharm Bull; 2021; 44(9):1174-1183. PubMed ID: 34471044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic drug monitoring of cefepime in a non-critically ill population: retrospective assessment and potential role for model-based dosing.
    Suttels V; André P; Thoma Y; Veuve F; Decosterd L; Guery B; Buclin T
    JAC Antimicrob Resist; 2022 Apr; 4(2):dlac043. PubMed ID: 35465238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individualized vancomycin dosing in obese patients: a two-sample measurement approach improves target attainment.
    Hong J; Krop LC; Johns T; Pai MP
    Pharmacotherapy; 2015 May; 35(5):455-63. PubMed ID: 26011138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
    Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
    Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A hybrid machine learning/pharmacokinetic approach outperforms maximum a posteriori Bayesian estimation by selectively flattening model priors.
    Hughes JH; Keizer RJ
    CPT Pharmacometrics Syst Pharmacol; 2021 Oct; 10(10):1150-1160. PubMed ID: 34270885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bayesian method application: Integrating mathematical modeling into clinical pharmacy through vancomycin therapeutic monitoring.
    Chen A; Gupta A; Do DH; Nazer LH
    Pharmacol Res Perspect; 2022 Dec; 10(6):e01026. PubMed ID: 36398492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Closed-Loop Control for Precision Antimicrobial Delivery: An In Silico Proof-of-Concept.
    Herrero P; Rawson TM; Philip A; Moore LSP; Holmes AH; Georgiou P
    IEEE Trans Biomed Eng; 2018 Oct; 65(10):2231-2236. PubMed ID: 29989937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development of Novel Dosing Strategy According to the Area under the Concentration-Time Curve for Vancomycin].
    Oda K
    Yakugaku Zasshi; 2022; 142(11):1185-1190. PubMed ID: 36328448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individualized Vancomycin Dosing with Therapeutic Drug Monitoring and Pharmacokinetic Consultation Service: A Large-Scale Retrospective Observational Study.
    Kim SM; Lee HS; Hwang NY; Kim K; Park HD; Lee SY
    Drug Des Devel Ther; 2021; 15():423-440. PubMed ID: 33692613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiologically Based Pharmacokinetic Modeling of Vancomycin and its Comparison with Population Pharmacokinetic Model in Neonates.
    Cao A; Li Q; Han M; Liu Q; Liang H; Tan L; Guan Y
    J Clin Pharmacol; 2024 Sep; ():. PubMed ID: 39223982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
    Rybak MJ; Le J; Lodise TP; Levine DP; Bradley JS; Liu C; Mueller BA; Pai MP; Wong-Beringer A; Rotschafer JC; Rodvold KA; Maples HD; Lomaestro BM
    Pharmacotherapy; 2020 Apr; 40(4):363-367. PubMed ID: 32227354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.